Loki Therapeutics, Inc.

NY Doing business as Loki Therapeutics Inc.

UEI
NBHGLFBRHLG7
CAGE
9F3G8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
175 Irving Ave #1l, Brooklyn, NY 11237, USA
Website
lokitx.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Loki Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Clinical testing of listeria-TT and gemcitabine in a phase i clinical trial with pdac patients - abstract the overall… Grant · R42CA287679 National Cancer Institute $294,962

Quick answers

What is Loki Therapeutics, Inc.'s UEI?

Loki Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is NBHGLFBRHLG7.

What is Loki Therapeutics, Inc.'s CAGE code?

Loki Therapeutics, Inc.'s CAGE code is 9F3G8.

What is Loki Therapeutics, Inc.'s primary NAICS code?

Loki Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Loki Therapeutics, Inc. located?

Loki Therapeutics, Inc.'s physical address in SAM.gov is 175 Irving Ave #1l, Brooklyn, NY 11237, USA.

Is Loki Therapeutics, Inc. registered in SAM.gov?

Yes. Loki Therapeutics, Inc.'s SAM.gov registration is active through December 17, 2026.

What is Loki Therapeutics, Inc.'s most recent federal award?

Loki Therapeutics, Inc.'s most recent federal grant award is Clinical testing of listeria-TT and gemcitabine in a phase i clinical trial with pdac patients - abstract the overall… (R42CA287679), from National Cancer Institute, on June 1, 2024.

On GovTribe

See Loki Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login